Compound A induces sister chromatid exchanges in Chinese hamster ovary cells

被引:27
作者
Eger, EI [1 ]
Laster, MJ [1 ]
Winegar, R [1 ]
Han, C [1 ]
Gong, D [1 ]
机构
[1] SRI INT,MENLO PK,CA 94025
关键词
anesthetics; volatile; sevoflurane; degradation; metabolites; toxicity; compound A; genotoxicity; mutagenicity; sister chromatid exchanges;
D O I
10.1097/00000542-199704000-00022
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Compound A [CF2=C(CF3)OCH2F], a degradation product of sevoflurane [(CF3)(2)CHOCH2F], is a vinyl ether and may be an alkylating agent. Thus it is a potential genotoxin. Methods: The capacity of compound A to produce sister chromatid exchanges was measured in Chinese hamster ovary cells with and without metabolic activation. Concentrations of 11 to 468 ppm compound A were applied for 2 h, the Chinese hamster ovary cells were incubated for a further 34 h in the presence of bromodeoxyuridine, and then colcemid was added to produce arrest in metaphase. Coded slides of cells were examined blindly, and 50 chromosome spreads were counted for each test concentration. Results: The lowest concentration of compound A applied without metabolic activator (27 ppm) significantly increased (P < 0.001) sister chromatid exchanges, and increasing concentrations of compound A increased the incidence of exchanges. Metabolic activation did not increase the incidence of exchanges. Conclusions: Compound A increases sister chromatid exchanges at concentrations (27 ppm) obtained in low-flow systems when sevoflurane is used at concentrations approximating minimum alveolar concentration.
引用
收藏
页码:918 / 922
页数:5
相关论文
共 23 条
  • [1] Current issues in mutagenesis and carcinogenesis .67. IPCS harmonization of methods for the prediction and quantification of human carcinogenic/mutagenic hazard, and for indicating the probable mechanism of action of carcinogens
    Ashby, J
    Waters, MD
    Preston, J
    Adler, ID
    Douglas, GR
    Fielder, R
    Shelby, MD
    Anderson, D
    Sofuni, T
    Gopalan, HNB
    Becking, G
    SonichMullin, C
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1996, 352 (1-2) : 153 - 157
  • [2] LONG-DURATION, LOW-FLOW SEVOFLURANE ANESTHESIA USING 2 CARBON-DIOXIDE ABSORBENTS - QUANTIFICATION OF DEGRADATION PRODUCTS IN THE CIRCUIT
    BITO, H
    IKEDA, K
    [J]. ANESTHESIOLOGY, 1994, 81 (02) : 340 - 345
  • [3] Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers
    Eger, EI
    Koblin, DD
    Bowland, T
    Ionescu, P
    Laster, MJ
    Fang, ZX
    Gong, D
    Sonner, J
    Weiskopf, RB
    [J]. ANESTHESIA AND ANALGESIA, 1997, 84 (01) : 160 - 168
  • [4] Compound A: Solubility in saline and olive oil; Destruction by blood
    Eger, EI
    Ionescu, P
    Koblin, DD
    Weiskopf, RB
    [J]. ANESTHESIA AND ANALGESIA, 1996, 83 (04) : 849 - 853
  • [5] CHROMOSOME-ABERRATIONS AND SISTER CHROMATID EXCHANGES IN CHINESE-HAMSTER OVARY CELLS - EVALUATIONS OF 108 CHEMICALS
    GALLOWAY, SM
    ARMSTRONG, MJ
    REUBEN, C
    COLMAN, S
    BROWN, B
    CANNON, C
    BLOOM, AD
    NAKAMURA, F
    AHMED, M
    DUK, S
    RIMPO, J
    MARGOLIN, BH
    RESNICK, MA
    ANDERSON, B
    ZEIGER, E
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1987, 10 : 1 - 175
  • [6] TOXICITY OF COMPOUND-A IN RATS - EFFECT OF A 3-HOUR ADMINISTRATION
    GONSOWSKI, CT
    LASTER, MJ
    EGER, EI
    FERRELL, LD
    KERSCHMANN, RL
    [J]. ANESTHESIOLOGY, 1994, 80 (03) : 556 - 565
  • [7] TOXICITY OF COMPOUND-A IN RATS - EFFECT OF INCREASING DURATION OF ADMINISTRATION
    GONSOWSKI, CT
    LASTER, MJ
    EGER, EI
    FERRELL, LD
    KERSCHMANN, RL
    [J]. ANESTHESIOLOGY, 1994, 80 (03) : 566 - 573
  • [8] NEPHROTOXICITY IN RATS UNDERGOING A ONE-HOUR EXPOSURE TO COMPOUND-A
    KANDEL, L
    LASTER, MJ
    EGER, EI
    KERSCHMANN, RL
    MARTIN, J
    [J]. ANESTHESIA AND ANALGESIA, 1995, 81 (03) : 559 - 563
  • [9] INHALATION TOXICITY STUDY OF A HALOALKENE DEGRADANT OF SEVOFLURANE, COMPOUND A(PIFE), IN SPRAGUE-DAWLEY RATS
    KELLER, KA
    CALLAN, C
    PROKOCIMER, P
    DELGADOHERRERA, L
    FRIEDMAN, MB
    HOFFMAN, GM
    WOODING, WL
    CUSICK, PK
    KRASULA, RW
    [J]. ANESTHESIOLOGY, 1995, 83 (06) : 1220 - 1232
  • [10] MUTAGENS AS CARCINOGENS - DEVELOPMENT OF CURRENT CONCEPTS
    LAWLEY, PD
    [J]. MUTATION RESEARCH, 1989, 213 (01): : 3 - 25